BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3643169)

  • 1. Diethylstilbestrol-associated vaginal adenosis followed by clear cell adenocarcinoma.
    Sander R; Nuss RC; Rhatigan RM
    Int J Gynecol Pathol; 1986; 5(4):362-70. PubMed ID: 3643169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies of nuclear DNA in vaginal adenosis and clear-cell adenocarcinoma.
    Lewis JL; Nordqvist SR; Richart RM
    Am J Obstet Gynecol; 1973 Mar; 115(6):737-50. PubMed ID: 4688576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaginal adenosis, dysplasia, and clear cell adenocarcinoma after diethylstilbestrol treatment in pregnancy.
    Barber HR; Sommers SC
    Obstet Gynecol; 1974 May; 43(5):645-52. PubMed ID: 4822648
    [No Abstract]   [Full Text] [Related]  

  • 4. Transition of benign vaginal adenosis to clear cell carcinoma.
    Ghosh TK; Cera PJ
    Obstet Gynecol; 1983 Jan; 61(1):126-30. PubMed ID: 6823342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenocarcinoma of the vagina in young women. The stilbestrol-adenosis-adenocarcinoma of the vagina syndrome.
    Fetherston WC; Meyers A; Speckhard ME
    Wis Med J; 1972 Feb; 71(2):87-93. PubMed ID: 5060564
    [No Abstract]   [Full Text] [Related]  

  • 6. Vaginal bleeding and diethylstilbestrol exposure during pregnancy: relationship to genital tract clear cell adenocarcinoma and vaginal adenosis in daughters.
    Sharp GB; Cole P
    Am J Obstet Gynecol; 1990 Apr; 162(4):994-1001. PubMed ID: 2327468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaginal adenosis and clear cell carcinoma after 5-fluorouracil treatment for condylomas.
    Goodman A; Zukerberg LR; Nikrui N; Scully RE
    Cancer; 1991 Oct; 68(7):1628-32. PubMed ID: 1893363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prenatal diethylstilbestrol (DES) exposure. Recommendations of the Diethylstilbestrol-Adenosis (DESAD) Project for the identification and management of exposed individuals.
    Clin Pediatr (Phila); 1983 Feb; 22(2):139-43. PubMed ID: 6822019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaginal adenosis and adenocarcinoma in mice exposed prenatally or neonatally to diethylstilbestrol.
    Newbold RR; McLachlan JA
    Cancer Res; 1982 May; 42(5):2003-11. PubMed ID: 7066910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrauterine diethylstilbestrol exposure and its consequences: pathologic characteristics of vaginal adenosis, clear cell adenocarcinoma, and related lesions.
    Robboy SJ; Scully RE; Welch WR; Herbst AL
    Arch Pathol Lab Med; 1977 Jan; 101(1):1-5. PubMed ID: 576195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Six years' experience with screening of a diethylstilbestrol-exposed population.
    Mangan CE; Guintoli RL; Sedlacek TV; Rocereto T; Rubin E; Burtnett M; Mikuta JJ
    Am J Obstet Gynecol; 1979 Aug; 134(8):860-5. PubMed ID: 463989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The DES story.
    Gunning JE
    Obstet Gynecol Surv; 1976 Nov; 31(11):827-33. PubMed ID: 980278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colposcopic and pathologic features in two cases of DES-related vaginal clear-cell adenocarcinoma.
    Blythe JG; Michael H; Hodel KA
    J Reprod Med; 1983 Feb; 28(2):137-46. PubMed ID: 6834354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical vaginal adenosis and cervical ectropion. Association with clear cell adenocarcinoma in diethylstilbestrol-exposed offspring.
    Robboy SJ; Young RH; Welch WR; Truslow GY; Prat J; Herbst AL; Scully RE
    Cancer; 1984 Sep; 54(5):869-75. PubMed ID: 6537153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysplasia and cytologic findings in 4,589 young women enrolled in diethylstilbestrol-adenosis (DESAD) project.
    Robboy SJ; Szyfelbein WM; Goellner JR; Kaufman RH; Taft PD; Richard RM; Gaffey TA; Prat J; Virata R; Hatab PA; McGorray SP; Noller KL; Townsend D; Labarthe D; Barnes AB
    Am J Obstet Gynecol; 1981 Jul; 140(5):579-86. PubMed ID: 7195652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal adenocarcinoma in a gravida with prenatal DES exposure.
    Del Castillo H; Rubio PA; Farrell EM
    Int J Gynaecol Obstet; 1978-1979; 16(4):271-3. PubMed ID: 35386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant transformation of vaginal adenosis to clear cell carcinoma without prenatal diethylstilbestrol exposure: a case report and literature review.
    Pang L; Li L; Zhu L; Lang J; Bi Y
    BMC Cancer; 2019 Aug; 19(1):798. PubMed ID: 31409310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosis and clear-cell carcinoma of the vagina. An invitational sympotium. Introduction.
    Reagan JW
    J Reprod Med; 1975 Jul; 15(1):3-4. PubMed ID: 1167310
    [No Abstract]   [Full Text] [Related]  

  • 19. Cervical-vaginal adenosis after in utero exposure to synthetic estrogens.
    Sherman AI; Goldrath M; Berlin A; Vakhariya V; Banooni F; Michaels W; Goodman P; Brown S
    Obstet Gynecol; 1974 Oct; 44(4):531-45. PubMed ID: 4412373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clear cell carcinoma of the cervix and vagina in young women. A report of six cases with association of maternal stilbestrol therapy and adenosis of the vagina.
    Hill EC
    Am J Obstet Gynecol; 1973 Jun; 116(4):470-84. PubMed ID: 4709483
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.